rosiglitazone has been researched along with Hypercholesterolemia in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, E; Li, QQ; Liao, WT; Liu, BR; Luo, H; Shen, YG; Tang, XQ; Wu, N; Yang, HS; Yang, Y; Yue, XZ; Zhang, GM | 1 |
| Al Rouq, F; El Eter, E | 1 |
| Dias, C; Helou, CM; Volpini, RA | 1 |
| Akdag, H; Esen, A; Evcim, S; Gidener, S; Murat, N | 1 |
| Christopher, TA; Gao, E; Koch, W; Lau, WB; Liu, HR; Lopez, BL; Ma, XL; Qu, Y; Tao, L; Yue, TL | 1 |
| Cockerill, GW; Deb, R; Dunkley, M; Gaze, D; Gnaneswaran, Y; Howe, F; Jones, A; Loftus, IM; Nasr, H; Thompson, MM; Torsney, E | 1 |
| Hu, D; Li, Y; Liu, N; Ren, L; Sheng, Z; Tang, R | 1 |
| Alessi, A; Baroncini, LA; Brofman, PR; França Neto, OR; Noronha, Ld; Précoma, DB; Prim, C; Silva, RF | 1 |
| Li, Y; Liu, N; Ren, L; Sheng, Z; Tang, R; Zhi, H | 1 |
| Hu, W; Qiao, J | 1 |
| Aubert, JP; Bouée, S; Detournay, B; Fontbonne, A; Guillausseau, PJ; Halimi, S; Nachit, F | 1 |
| Batinic-Haberle, I; Christopher, TA; Gao, E; Liu, HR; Lopez, BL; Ma, XL; Ohlstein, EH; Tao, L; Teng, ZP; Willette, RN; Yue, TL | 1 |
| Christopher, TA; Gao, E; Liu, HR; Lopez, BL; Ma, XL; Ohlstein, EH; Tao, L; Willette, RN; Yue, TL | 1 |
| Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F | 1 |
| Han, KH; Hong, KH; Kim, JB; Kim, JJ; Ko, J; Pak, YK; Park, SW; Ryu, J | 1 |
| Almazan, F; Chen, Y; Green, SR; Ho, J; Li, A; Quehenberger, O | 1 |
| Abchee, AB; Alam, S; Ayach, K; Dakik, HA; Mehio-Sibai, A; Nasrallah, A; Sawaya, J; Sibai, T; Skouri, HN; Wehbeh, C | 1 |
| Bujko, J; Dzieniszewski, J; Nowicka, G; Tacikowski, T; Walewska-Zielecka, B | 1 |
| Liu, XM; Luo, F; Wang, ZH | 1 |
| Németh, J; Pankucsi, C; Peitl, B; Szilvássy, Z | 1 |
20 other study(ies) available for rosiglitazone and Hypercholesterolemia
| Article | Year |
|---|---|
Chronological in vivo imaging reveals endothelial inflammation prior to neutrophils accumulation and lipid deposition in HCD-fed zebrafish.
Topics: Animals; Animals, Genetically Modified; Anti-Inflammatory Agents; Atherosclerosis; Cholesterol, Dietary; Disease Models, Animal; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypercholesterolemia; Inflammation; Interleukin-1beta; Lipid Metabolism; Microscopy, Confocal; Neutrophil Infiltration; Plaque, Atherosclerotic; PPAR gamma; Rosiglitazone; Time Factors; Tumor Necrosis Factor-alpha; Zebrafish; Zebrafish Proteins | 2019 |
PPAR-γ activator induces neuroprotection in hypercholesterolemic rats subjected to global cerebral ischemia/reperfusion injury: in vivo and in vitro inhibition of oxidative stress.
Topics: Animals; Brain Edema; Brain Ischemia; Dose-Response Relationship, Drug; Glutathione; Hypercholesterolemia; Interleukin-6; Lipid Peroxidation; Male; Neuroprotective Agents; Oxidative Stress; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2014 |
Rosiglitazone did not induce acute kidney injury in normocholesterolemic rats despite reduction in glomerular filtration rate.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Cholesterol; Glomerular Filtration Rate; Hypercholesterolemia; Hypoglycemic Agents; Lipid Metabolism; Lipocalin-2; Lipocalins; Magnesium; Male; Proto-Oncogene Proteins; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Thiobarbituric Acid Reactive Substances | 2013 |
Acute effect of rosiglitazone on relaxation responses in hypercholesterolemic corpus cavernosum.
Topics: Acetylcholine; Animals; Body Weight; Cholesterol, Dietary; Endothelium, Vascular; Hypercholesterolemia; Hypoglycemic Agents; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Penis; PPAR gamma; Rabbits; Rosiglitazone; Thiazolidinediones; Vasodilator Agents | 2016 |
Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Caspase 3; Gene Expression Regulation, Enzymologic; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peroxidase; PPAR gamma; Rabbits; Rosiglitazone; Thiazolidinediones | 2009 |
Rosiglitazone reduces the development and rupture of experimental aortic aneurysms.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Aortic Rupture; Apolipoproteins E; Blood Glucose; Body Weight; Cholesterol; Disease Models, Animal; E-Selectin; Humans; Hypercholesterolemia; Hypoglycemic Agents; Interleukin-6; Mice; Mice, Knockout; PPAR gamma; Receptors, Angiotensin; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2009 |
The inhibitory effects of rosiglitazone on cardiac hypertrophy through modulating the renin-angiotensin system in diet-induced hypercholesterolemic rats.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Cardiomegaly; Cholesterol, Dietary; Hypercholesterolemia; Irbesartan; Male; Myocardium; PPAR gamma; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Rosiglitazone; Tetrazoles; Thiazolidinediones | 2010 |
Rosiglitazone and vascular injury in hypercholesterolemic rabbits: neointimal formation assessment.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Disease Models, Animal; Hypercholesterolemia; Iliac Artery; Male; Neointima; Rabbits; Random Allocation; Rosiglitazone; Thiazolidinediones | 2010 |
Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.
Topics: Angiotensin II; Animals; Aortic Diseases; Atherosclerosis; Blotting, Western; Cardiovascular Agents; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Hypercholesterolemia; Immunohistochemistry; Lipids; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Radioimmunoassay; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors | 2011 |
Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome.
Topics: Adult; Body Mass Index; C-Reactive Protein; Cells, Cultured; Fatty Acid-Binding Proteins; Female; Gene Expression Regulation; Granulosa Cells; Humans; Hypercholesterolemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; PPAR gamma; RNA, Messenger; Rosiglitazone; Severity of Illness Index; Testosterone; Thiazolidinediones; Up-Regulation | 2011 |
A real-life study of the use, effectiveness and tolerability of rosiglitazone in France: the AVANCE study.
Topics: Adult; Aged; Blood Glucose; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; France; Glycated Hemoglobin; Humans; Hypercholesterolemia; Hypertension; Hypoglycemic Agents; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Practice Patterns, Physicians'; Rosiglitazone; Smoking; Surveys and Questionnaires; Thiazolidinediones; Time Factors; Treatment Outcome | 2012 |
Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia.
Topics: Animals; Antioxidants; Blood Vessels; Carotid Arteries; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Hypercholesterolemia; In Vitro Techniques; Lipids; Male; Nitrates; Nitric Oxide; Nitrites; Rabbits; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factors; Tyrosine; Vasodilation | 2003 |
Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion.
Topics: Animals; Apoptosis; Diet; Enzyme Induction; Hypercholesterolemia; In Situ Nick-End Labeling; Male; MAP Kinase Signaling System; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rabbits; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors | 2004 |
Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman.
Topics: Adult; Anxiety Disorders; Apgar Score; Atorvastatin; Chronic Disease; Diabetes Complications; Epilepsy; Female; Gliclazide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypoglycemic Agents; Infant, Newborn; Obesity, Morbid; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pyrroles; Rosiglitazone; Thiazolidinediones | 2004 |
HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Topics: Anilides; Animals; Aorta; Cells, Cultured; Chemokine CCL2; Chemotaxis, Leukocyte; Depression, Chemical; Diet, Atherogenic; Down-Regulation; Drug Evaluation, Preclinical; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Mevalonic Acid; Mice; Mice, Inbred C57BL; Monocytes; Polyisoprenyl Phosphates; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Chemokine; RNA, Messenger; Rosiglitazone; Sesquiterpenes; Simvastatin; Thiazolidinediones | 2005 |
The mouse CCR2 gene is regulated by two promoters that are responsive to plasma cholesterol and peroxisome proliferator-activated receptor gamma ligands.
Topics: Animals; Cells, Cultured; Cholesterol; Gene Expression Regulation; Hypercholesterolemia; Mice; Mice, Inbred C57BL; Monocytes; PPAR gamma; Promoter Regions, Genetic; Receptors, CCR2; Receptors, Chemokine; Rosiglitazone; Thiazolidinediones | 2005 |
Prevalence of coronary artery calcium among asymptomatic men and women in a developing country: comparison with the USA data.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Calcinosis; Calcium; Comorbidity; Coronary Artery Disease; Coronary Vessels; Developing Countries; Diabetes Mellitus, Type 2; Female; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Lebanon; Male; Middle Aged; Prevalence; Risk Factors; Rosiglitazone; Smoking; Thiazolidinediones; Tomography, X-Ray Computed; United States | 2005 |
[Effect of high-fat diet, rosiglitazone on lipid profile, insulin resistance and liver steatosis development].
Topics: Animals; Blood Glucose; Cholesterol; Dietary Fats; Fatty Liver; Hypercholesterolemia; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Peptides; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Triglycerides | 2005 |
[Effect of PPARgamma agonist rosiglitazone on regression of the atherosclerotic plaques in rabbits].
Topics: Animals; Aorta; Atherosclerosis; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Fibrinolytic Agents; Hypercholesterolemia; Male; PPAR gamma; Rabbits; Random Allocation; Rosiglitazone; Thiazolidinediones; Tunica Intima | 2005 |
Insulin sensitization induced by oral cicletanine in conscious rabbits.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Pressure; Blood Vessels; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Glucose Clamp Technique; Heart Rate; Hypercholesterolemia; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Myocardium; Nitric Oxide; Pyridines; Rabbits; Rosiglitazone; Thiazolidinediones | 2006 |